Bench to bedside study of a targetable enzyme controlling aggressive prostate cancer

Prostate cancer represents a major health challenge and there is currently no effective treatment once it has advanced to the aggressive, metastatic stage. A new has revealed a key cellular mechanism that contributes to aggressive prostate cancer, and supporting a new clinical trial.

Quelle: Sciencedaily